Six weeks of treatment with intranasal insulin rescued brain insulin signalling dysfunction, ameliorated cognitive impairments, inhibited JNK activation, increased neurogenesis and reduced Aβ accumulation and plaques in 4.5‐month‐old APP/PS1 mice (Mao et al., 2016). This evidence concerns the gene INS and Cognitive impairment.